These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 6316462

  • 1. [Treatment of lung cancer by a cooperative group: EORTC Lung Cancer Working Party (Belgium)].
    Klastersky J, Sculier JP.
    Rev Med Brux; 1983 Sep; 4(7):485-9. PubMed ID: 6316462
    [No Abstract] [Full Text] [Related]

  • 2. Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma.
    Mazzei T, Marino C, Nozzoli F, Lopes-Pegna A, Righi R, Santomaggio C, Lamanna S, Periti P.
    Chemioterapia; 1984 Feb; 3(1):16-8. PubMed ID: 6100172
    [Abstract] [Full Text] [Related]

  • 3. Chemotherapy of inoperable bronchogenic carcinoma.
    Behera D, Malik SK.
    Indian J Chest Dis Allied Sci; 1985 Feb; 27(3):175-89. PubMed ID: 3017850
    [No Abstract] [Full Text] [Related]

  • 4. [Chemotherapy in non-small cell bronchial carcinoma. 12 years' experience in an international cooperative group: EORTC Lung Cancer Working Party].
    Lacroix H, Sculier JP.
    Bull Cancer; 1990 Feb; 77(10):997-1005. PubMed ID: 2174277
    [Abstract] [Full Text] [Related]

  • 5. High-dose cisplatin with fluid and mannitol-induced diuresis in advanced lung cancer: a phase II clinical trial of the EORTC Lung Cancer Working Party (Belgium).
    De Jager R, Longeval E, Klastersky J.
    Cancer Treat Rep; 1980 Feb; 64(12):1341-6. PubMed ID: 6258791
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Conditions suitable for chemotherapy of lung cancer].
    Fukuoka M, Takada M, Negoro S, Tamai S, Matsui K, Sakai N, Ryu S, Yoshinaga T.
    Gan No Rinsho; 1983 Aug; 29(10):1223-8. PubMed ID: 6313983
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Intra-arterial drug infusion via the bronchial artery in the treatment of bronchogenic carcinoma].
    Wang ZT.
    Zhonghua Fang She Xue Za Zhi; 1988 Aug; 22(4):216-9. PubMed ID: 3145173
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical evaluation of procarbazine and fluorouracil in advanced lung cancer.
    Pacilio G, Puzziello T.
    Bronches; 1971 Aug; 21(4):402. PubMed ID: 4340778
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical study of combination chemotherapy with continuously infused peplomycin (PEP), cis-dichlorodiammineplatinum (II) (CDDP) and mitomycin C (MMC) (PPM therapy)].
    Goto T, Furuta I, Urata A, Fukushima M, Okuma K, Oyama A, Murakami M, Ariyoshi Y, Nishimura M, Kurita S.
    Nihon Gan Chiryo Gakkai Shi; 1983 Dec 20; 18(8):2054-60. PubMed ID: 6201578
    [No Abstract] [Full Text] [Related]

  • 19. Hexamethylmelamine in inoperable bronchogenic carcinoma.
    Takita H.
    N Y State J Med; 1972 Feb 15; 72(4):477-80. PubMed ID: 4334448
    [No Abstract] [Full Text] [Related]

  • 20. [Chemotherapy of lung cancer].
    Dement'eva NP.
    Sov Med; 1984 Feb 15; (11):55-61. PubMed ID: 6084308
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.